Our recent findings also demonstrate that METTL3 expression is significantly deceased in IDH-wildtype glioma, and METTL3 expression is positively associated with a higher malignant grade and poorer prognosis of IDH-wildtype gliomas but not IDH-mutant gliomas [27]. The gene discussed is METTL3; the disease is central nervous system cancer.